Research identifies plant’s anti-cancer property

Ayurvedic purification does away with toxicity of Bhallataka or varnish tree

March 05, 2021 08:33 pm | Updated March 07, 2021 05:30 pm IST - MALAPPURAM

Bhallataka or marking nut.

Bhallataka or marking nut.

A group of researchers from Kottakkal Arya Vaidya Sala’s Centre for Medicinal Plants Research (CMPR) has come up with evidence to prove that a poisonous medicinal plant available in the State can be effectively used against several illnesses, including cancer, after purification.

A study conducted by a team led by C.T. Sulaiman, senior scientist

at CMPR’s phytochemistry division, found that the traditional

purification process suggested by Ayurveda classics for Bhallataka or ‘marking nut’ could not only do away with its toxicity, but also

drastically enhance its anti-cancer properties. “This finding can lead to new insights into cancer research,” said Dr. Sulaiman.

Locally known as cheru or varnish tree, Bhallataka is widely found

across the country and its medicinal properties have been well

established. The Drugs and Cosmetics Act of 1940 has classified Bhallataka as a poisonous plant. Its fruit is used in Ayurveda to treat diseases like nervous debility, rheumatism, epilepsy, sciatica and asthma. But if used raw, it can cause irritation, blisters, toxicity and contact dermatitis.

The CMPR study has validated the purification process named Shodhana suggested by Ayurveda classics. Chemical comparison of raw and purified samples of Bhallataka showed that the traditional purification process imparted chemical transformations to toxic compounds and converted them to non-toxic forms.

“Pharmacological and toxicological studies in experimental animals showed that purification reduced the toxic effects and enhanced its anti-cancer activity,” said Indira Balachandran, project director who supervised the research supported by the Navajbai Ratan Tata Trust, Mumbai.

Dr. Indira said that the traditional system of purification could

positively impact the chemical, pharmacological and toxicological

profile of herbal drugs.

Renowned publisher Elsevier has published the study in its

international journal Regulatory Toxicology and Pharmacology released from the U.S.

The other members of the research team are Deepak M., Lijini K.R. and Anandan E.M. from Kottakkal Arya Vaidya Sala and Praveen K.T. from JSS College of Pharmacy, Ooty.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.